Use of intestinal alkaline phosphate may help prevent C. difficile infections, based on preliminary testing on mice, according to research presented at the Annual American College of Surgeons Clinical Congress and reported by ABC.
For the study, researchers administered IAP to mice on antibiotics and discovered a 10-fold increase in C. difficile bacteria in the mice's stool and a 10-fold decrease in IL-1, an inflammatory marker. Previous researcher has shown IAP, a naturally occurring enzyme in humans, had no negative side effects in humans.
Researchers hope to start clinical trials with human participants soon.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
For the study, researchers administered IAP to mice on antibiotics and discovered a 10-fold increase in C. difficile bacteria in the mice's stool and a 10-fold decrease in IL-1, an inflammatory marker. Previous researcher has shown IAP, a naturally occurring enzyme in humans, had no negative side effects in humans.
Researchers hope to start clinical trials with human participants soon.
More Articles on Patient Safety:
6 Tips for Proper Housekeeping in an Ambulatory Surgery Center
3 Best Practices for Public Reporting of Quality Information
Joint Commission Releases ASC, Office-Based Surgery 2013 Patient Safety Goals